Your browser doesn't support javascript.
loading
A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors.
Lee, Jih-Hsiang; Chen, Tom Wei-Wu; Hsu, Chih-Hung; Yen, Yu-Hsin; Yang, James Chih-Hsin; Cheng, Ann-Lii; Sasaki, Shun-Ichi; Chiu, LiYin Lillian; Sugihara, Masahiro; Ishizuka, Tomoko; Oguma, Toshihiro; Tajima, Naoyuki; Lin, Chia-Chi.
Afiliación
  • Lee JH; National Taiwan University Hospital, Hsin-Chu Branch No. 25, Lane 442, Sec. 1, Jingguo Rd, Hsinchu City, 300, Taiwan.
  • Chen TW; National Taiwan University Hospital, 7 Chung Shan S Rd, Taipei, 10002, Taiwan.
  • Hsu CH; National Taiwan University Hospital, 7 Chung Shan S Rd, Taipei, 10002, Taiwan.
  • Yen YH; Graduate Institute of Oncology, National Taiwan University College of Medicine, 7 Chung Shan S Rd, Taipei, 10002, Taiwan.
  • Yang JC; National Taiwan University Hospital, 7 Chung Shan S Rd, Taipei, 10002, Taiwan.
  • Cheng AL; National Taiwan University Hospital, 7 Chung Shan S Rd, Taipei, 10002, Taiwan.
  • Sasaki SI; Graduate Institute of Oncology, National Taiwan University College of Medicine, 7 Chung Shan S Rd, Taipei, 10002, Taiwan.
  • Chiu LL; National Taiwan University Hospital, 7 Chung Shan S Rd, Taipei, 10002, Taiwan.
  • Sugihara M; Graduate Institute of Oncology, National Taiwan University College of Medicine, 7 Chung Shan S Rd, Taipei, 10002, Taiwan.
  • Ishizuka T; Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo, 140-8710, Japan.
  • Oguma T; Daiichi Sankyo Co., Ltd., 7F-1, No. 308, Sec. 2, Bade Rd, Zhongshan Dist., Taipei City, 104, Taiwan.
  • Tajima N; Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo, 140-8710, Japan.
  • Lin CC; Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo, 140-8710, Japan.
Invest New Drugs ; 38(1): 99-110, 2020 02.
Article en En | MEDLINE | ID: mdl-30825104
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirroles / Receptores de Factor Estimulante de Colonias de Granulocitos y Macrófagos / Aminopiridinas / Neoplasias Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Año: 2020 Tipo del documento: Article País de afiliación: Taiwán
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirroles / Receptores de Factor Estimulante de Colonias de Granulocitos y Macrófagos / Aminopiridinas / Neoplasias Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Año: 2020 Tipo del documento: Article País de afiliación: Taiwán